Back to search
Haemophilia A and B With and Without Inhibitors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Haemophilia A and B With and Without Inhibitors trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Haemophilia A and B With and Without Inhibitors trials you may qualify forThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called marstacimab) for the potential treatment of hemophilia…
The purposes of this open-label, multicenter III clinical trial are to evaluate the safety and efficacy of long-term preventive treatment with KN057 in Haemophi…
Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in particip…
This study will test how well a new medicine called concizumab works in the body of people with haemophilia A or B without inhibitors. The purpose is to show th…
This study will test how well a new medicine called concizumab works for participants who have haemophilia A or B with or without inhibitors. The purpose is to…